Clinical practice. Allergic rhinitis, N Engl J Med, vol.372, pp.456-63, 2015. ,
Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen), Allergy, vol.63, issue.86, pp.8-160, 2008. ,
URL : https://hal.archives-ouvertes.fr/hal-00596392
Prevalence and rate of diagnosis of allergic rhinitis in Europe, Eur Respir J, vol.24, pp.758-64, 2004. ,
INSTANT: national survey of allergic rhinitis in a French adult population based-sample, Presse Med, vol.38, pp.1220-1229, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-00595791
Functional limitations and workdays lost associated with chronic rhinosinusitis and allergic rhinitis, Am J Rhinol Allergy, vol.26, pp.120-122, 2012. ,
Health-related quality of life assessment in young adults with seasonal allergic rhinitis, Allergy, vol.56, pp.313-320, 2001. ,
Allergic rhinitis: burden of illness, quality of life, comorbidities, and control, Immunol Allergy Clin North Am, vol.36, pp.235-283, 2016. ,
Multi-morbidities of allergic rhinitis in adults: European academy of allergy and clinical immunology task force report, Clin Transl Allergy, vol.7, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01760907
Pollen-related allergy in Europe, Allergy, vol.53, pp.567-78, 1998. ,
Prevalence of patent and latent atopy among a general normal adult population in the south east of France by RAST investigation and correlation with circulating total IgE levels, Allergol Immunopathol (Madr), vol.21, pp.211-220, 1993. ,
A systematic review and economic evaluation of subcutaneous and sublingual allergen immunotherapy in adults and children with seasonal allergic rhinitis, Health Technol Assess, vol.17, pp.1-322, 2013. ,
The effect of a new communication template on anticipated willingness to initiate or resume allergen immunotherapy: an internet-based patient survey, Allergy Asthma Clin Immunol, vol.11, p.17, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01156541
Benefit of SLIT and SCIT for allergic rhinitis and asthma, Curr Allergy Asthma Rep, vol.16, p.88, 2016. ,
Clinical efficacy of 300IR 5-grass pollen sublingual tablet in a US study: the importance of allergen-specific serum IgE, J Allergy Clin Immunol, vol.130, p.1321, 2012. ,
Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis, J Allergy Clin Immunol, vol.120, pp.1338-1383, 2007. ,
Sustained 3-year efficacy of pre-and coseasonal 5-grass-pollen sublingual immunotherapy tablets in patients with grass pollen-induced rhinoconjunctivitis, J Allergy Clin Immunol, vol.128, pp.559-66, 2011. ,
A new instrument for the assessment of patient-defined benefit in the treatment of allergic rhinitis, Allergy, vol.66, pp.665-70, 2011. ,
Evaluation of patients' expectations and benefits in the treatment of allergic rhinitis with a new tool: the patient benefit index-the benefica study, Allergy Asthma Clin Immunol, vol.11, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01144165
Allergic rhinitis and its impact on asthma, J Allergy Clin Immunol, vol.108, pp.147-334, 2001. ,
URL : https://hal.archives-ouvertes.fr/hal-02099400
, World Health Organization. WHO Collaborating Centre for Drug Statistics Methodology: guidelines for ATC classification and DDD assignment. Oslo: WHO-CCDSM, 2017.
Agreement of efficacy assessments for five-grass pollen sublingual tablet immunotherapy, Allergy, vol.64, pp.166-71, 2009. ,
Safety and tolerability of 5-grass pollen tablet sublingual immunotherapy: pooled analysis and clinical review, Expert Opin Drug Saf, vol.14, p.68, 2015. ,
Optimum treatment strategies for polyallergic patients-analysis of a large observational trial, Curr Med Res Opin, vol.31, pp.2249-59, 2015. ,
One season of treatment with 5 grass pollen tablets in adults demonstrated a reduction in disease symptoms and impacts. Findings of the SMILE study, European Academy of Allergy and Clinical Immunology (EAACI) Annual Meeting, 2013. ,